Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study
Pharm. pract. (Granada, Internet)
; 20(2): 1-8, Apr.-jun. 2022. tab
Artigo
em Inglês
| IBECS
| ID: ibc-210411
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Background:
Oxaliplatin is a third-generation platinum compound that has efficacy against colorectal cancer. Hypersensitivity reactions during oxaliplatin infusion are a key problem during its use, with the varying incidences and deficiencies of clearly identified risk factors.Objective:
To determine the incidence, severity and risk factors of oxaliplatin-related hypersensitivity reaction (HSR).Method:
This retrospective study investigated 245 colorectal cancer patients (1,690 treatment cycles) receiving care at King Chulalongkorn Memorial Hospital, Thai Red Cross society between January 1, 2015 and December 31, 2019. The patients demographic data, laboratory data and clinical features suggesting hypersensitivity reactions to oxaliplatin were reviewed. The Fishers Exact test and unpaired t-test were used to determine the differences among patients with and without oxaliplatin HSR. The potential risk factors for oxaliplatin HSR were analyzed for statistical significance by logistic regression. (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Neoplasias Colorretais
/
Oxaliplatina
/
Hipersensibilidade
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Pharm. pract. (Granada, Internet)
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Chulalongkorn University/Thailand